Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 CAD | -1.19% | -4.05% | -22.43% |
Valuation
Fiscal Period: November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 312.4 | 231 | 400.5 | 278.8 | 105.8 | 77.25 | - | - |
Enterprise Value (EV) 1 | 312.4 | 231 | 400.5 | 278.8 | 105.8 | 77.25 | 77.25 | 77.25 |
P/E ratio | -19.1 x | -7.99 x | -9.63 x | -4.31 x | -1.75 x | -160 x | 8.2 x | 3.07 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 3.72 x | 2.79 x | 4.46 x | 2.56 x | 0.96 x | 0.64 x | 0.57 x | 0.5 x |
EV / Revenue | 3.72 x | 2.79 x | 4.46 x | 2.56 x | 0.96 x | 0.64 x | 0.57 x | 0.5 x |
EV / EBITDA | 728 x | -26 x | -21.4 x | -8.71 x | -26.9 x | 3.74 x | 2.74 x | 2.05 x |
EV / FCF | -33.5 x | -13.6 x | - | - | - | 10.3 x | 2.69 x | 1.8 x |
FCF Yield | -2.98% | -7.36% | - | - | - | 9.71% | 37.2% | 55.6% |
Price to Book | 9.46 x | 57.2 x | 17.5 x | -9.23 x | -3.51 x | - | - | - |
Nbr of stocks (in thousands) | 19,238 | 19,253 | 23,780 | 23,785 | 49,202 | 45,981 | - | - |
Reference price 2 | 16.24 | 12.00 | 16.84 | 11.72 | 2.150 | 1.680 | 1.680 | 1.680 |
Announcement Date | 2/25/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 84 | 82.66 | 89.73 | 108.7 | 110.5 | 120 | 135.3 | 154.4 |
EBITDA 1 | 0.4292 | -8.877 | -18.75 | -32.01 | -3.938 | 20.64 | 28.18 | 37.68 |
EBIT 1 | -11.31 | -22.47 | -32.43 | -54.2 | -14.36 | 15.98 | 34.4 | 56.87 |
Operating Margin | -13.47% | -27.19% | -36.14% | -49.85% | -13% | 13.32% | 25.44% | 36.84% |
Earnings before Tax (EBT) 1 | -16.61 | -28.37 | -40.69 | -63.56 | -31.81 | 3.868 | 24.59 | 51.12 |
Net income 1 | -16.61 | -28.37 | -40.77 | -64.16 | -32.38 | 0.2082 | 14.43 | 29.91 |
Net margin | -19.77% | -34.32% | -45.44% | -59% | -29.3% | 0.17% | 10.67% | 19.38% |
EPS 2 | -0.8504 | -1.502 | -1.748 | -2.721 | -1.229 | -0.0105 | 0.2050 | 0.5470 |
Free Cash Flow 1 | -9.319 | -17 | - | - | - | 7.503 | 28.74 | 42.97 |
FCF margin | -11.09% | -20.57% | - | - | - | 6.25% | 21.25% | 27.84% |
FCF Conversion (EBITDA) | - | - | - | - | - | 36.36% | 101.97% | 114.05% |
FCF Conversion (Net income) | - | - | - | - | - | 3,602.96% | 199.19% | 143.67% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/25/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/21/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: November | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 24.1 | 23.4 | 24.97 | 28.7 | 29.09 | 26.82 | 23.28 | 28.09 | 31.69 | 22.08 | 29.61 | 32.02 | 36.09 | 31.45 | 35.1 |
EBITDA | -7.07 | - | -15.17 | - | - | -5.244 | -8.086 | 2.91 | 6.7 | -0.3357 | - | - | - | - | - |
EBIT 1 | -10.36 | -9.735 | -27.16 | -7.612 | -7.753 | -7.285 | -10.54 | 0.073 | 3.608 | -3.053 | 2.632 | 6.027 | 10.42 | 9.13 | 9.211 |
Operating Margin | -43% | -41.6% | -108.79% | -26.52% | -26.65% | -27.16% | -45.27% | 0.26% | 11.38% | -13.82% | 8.89% | 18.82% | 28.88% | 29.04% | 26.24% |
Earnings before Tax (EBT) 1 | -12.7 | -11.36 | -29.29 | -10.2 | -10.58 | -13.94 | -13.11 | -0.8377 | -3.624 | -5.941 | -0.5428 | 2.921 | 7.475 | 5.746 | 6.017 |
Net income 1 | -12.72 | -11.39 | -29.45 | -10.41 | -10.77 | -14.07 | -13.28 | -1.008 | -3.723 | -6.09 | -0.6113 | 2.358 | 6.194 | 5.125 | 5.368 |
Net margin | -52.79% | -48.67% | -117.95% | -36.27% | -37.02% | -52.46% | -57.06% | -3.59% | -11.75% | -27.58% | -2.06% | 7.36% | 17.16% | 16.3% | 15.29% |
EPS 2 | -0.5141 | -0.4539 | -1.261 | -0.4414 | -0.4898 | -0.5918 | -0.5268 | -0.0405 | -0.0405 | -0.1359 | -0.0227 | 0.0410 | 0.1047 | 0.007000 | 0.0615 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/24/22 | 4/13/22 | 7/14/22 | 10/13/22 | 2/28/23 | 4/12/23 | 7/12/23 | 9/26/23 | 2/21/24 | 4/10/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -9.32 | -17 | - | - | - | 7.5 | 28.7 | 43 |
ROE (net income / shareholders' equity) | -50.3% | -162% | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | 1.720 | 0.2100 | 0.9600 | -1.270 | -0.6100 | - | - | - |
Cash Flow per Share 2 | -0.2300 | -0.8800 | -0.8000 | -0.8400 | -0.2900 | 0.1900 | 0.3900 | 0.7700 |
Capex 1 | 1.61 | 0.04 | - | 1.34 | 0.43 | 0.68 | 0.34 | 0.34 |
Capex / Sales | 1.92% | 0.05% | - | 1.23% | 0.39% | 0.57% | 0.25% | 0.22% |
Announcement Date | 2/25/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/21/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.43% | 56.14M | |
-0.12% | 92.26B | |
-2.63% | 38.11B | |
-12.51% | 32.9B | |
+66.54% | 26.51B | |
-13.05% | 15.75B | |
-6.47% | 13.36B | |
-10.50% | 11.65B | |
-49.11% | 10.12B | |
+187.82% | 9.78B |
- Stock Market
- Equities
- TH Stock
- Financials Theratechnologies Inc.